SGLT-2 inhibition with canagliflozin: a new option for the treatment of type 2 diabetes
Saved in:
| Published in | Deutsche medizinische Wochenschrift (1946) Vol. 139 Suppl 2; p. S52 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | German |
| Published |
Germany
01.02.2014
|
| Subjects | |
| Online Access | Get more information |
Cover
Loading…
| Author | Seufert, J |
|---|---|
| Author_xml | – sequence: 1 givenname: J surname: Seufert fullname: Seufert, J organization: Abteilung Endokrinologie und Diabetologie, Klinik für Innere Medizin II, Universitätsklinikum Freiburg |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24481633$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1j8tKxDAUQIMoOo5uXUp-IJqbR9O4k0FHoeDCEZdD0tzYwDQtbWQYv17wsTqbw4FzTo7zkJGQK-A3wLW-nRnnUjKQ2loLR2QBSlqmFMhTciaUqqGSckHeX9fNhgmacpd8KmnIdJ9KR1uX3ccuxd3wlfIddTTjng7jjxCHiZYOaZnQlR5zoUOk5TAiFTQk57HgfEFOotvNePnHJXl7fNisnljzsn5e3TdsBAWF6SDa2uhgatsqZUTtQRmUUEvuXSsNcBWrYJxzoFFIG5zyLSisojUaQiWW5Pq3O376HsN2nFLvpsP2_1B8Aw7eTtk |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM |
| DOI | 10.1055/s-0033-1359991 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| DocumentTitleAlternate | SGLT-2-Inhibition mit Canagliflozin: Eine neue Option in der Therapie des Typ-2-Diabetes |
| EISSN | 1439-4413 |
| ExternalDocumentID | 24481633 |
| Genre | Journal Article Review |
| GroupedDBID | CGR CUY CVF ECM EIF NPM |
| ID | FETCH-LOGICAL-p141t-5d2c875d789c44728b147e31830bac37104f6d7aaa15e239da4bc14e6f9751d62 |
| IngestDate | Tue Jul 04 17:18:10 EDT 2023 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | German |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-p141t-5d2c875d789c44728b147e31830bac37104f6d7aaa15e239da4bc14e6f9751d62 |
| PMID | 24481633 |
| ParticipantIDs | pubmed_primary_24481633 |
| PublicationCentury | 2000 |
| PublicationDate | 2014-Feb |
| PublicationDateYYYYMMDD | 2014-02-01 |
| PublicationDate_xml | – month: 02 year: 2014 text: 2014-Feb |
| PublicationDecade | 2010 |
| PublicationPlace | Germany |
| PublicationPlace_xml | – name: Germany |
| PublicationTitle | Deutsche medizinische Wochenschrift (1946) |
| PublicationTitleAlternate | Dtsch Med Wochenschr |
| PublicationYear | 2014 |
| Score | 1.985611 |
| SecondaryResourceType | review_article |
| SourceID | pubmed |
| SourceType | Index Database |
| StartPage | S52 |
| SubjectTerms | Blood Glucose - metabolism Blood Pressure - drug effects Body Weight - drug effects Canagliflozin Clinical Trials, Phase III as Topic Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Diabetic Nephropathies - blood Diabetic Nephropathies - drug therapy Dose-Response Relationship, Drug Double-Blind Method Glucosides - adverse effects Glucosides - therapeutic use Glycated Hemoglobin A - metabolism Humans Hypoglycemic Agents - adverse effects Hypoglycemic Agents - therapeutic use Kidney - drug effects Kidney Concentrating Ability - drug effects Randomized Controlled Trials as Topic Sodium-Glucose Transporter 2 - antagonists & inhibitors Thiophenes - adverse effects Thiophenes - therapeutic use |
| Title | SGLT-2 inhibition with canagliflozin: a new option for the treatment of type 2 diabetes |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/24481633 |
| Volume | 139 Suppl 2 |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1NT9wwEIYtPi69VFRQWtoiH7itXNaOHSe9VYWCECCkXQQ3ZMe2GgmyK7pc9tczYyf7AUVtuVhRHCWSn83sjDPzDiF7ucmsNsGz3Lqcgf8vmIWYjaGyjDWy7xXHauSz8_z4Up5cq-t5l85YXTKxX6vpH-tKXkMVzgFXrJL9D7Kzm8IJOAa-MAJhGP-J8eDodMhEr25-1TamXrWZ5JjScluH29G0blI1c4PlKeOlvMJ5ijmmCSzvxC66rAf-YQIhsI-f4aeoRFLFJBwYGzi8r1NLH16iGvBsW2HgH0JbDnSyuLPAZZeMjH8MyRpK_EwsU7HozFxmZS92HO2JBcM3SDq0zwxyX6F2xW8We8bxTKE_unghLML4LuIBP6MA5zD7--wTgexuapWs6gJN3fnFWSfPqdT-8rNR_Lm9_kkgER2K4QZ520YC9HvC-o6sOL9JrhJSOkdKESldQvqNGgpAaQJKASgFoHQGlI4CRaBU0A7oFrn8eTj8ccza3hdszCWfMOVEBaGk00VZSalFYbnUuF-d9a2pMvALZcidNsZw5UVWOiNtxaXPQ6kVd7l4T9aaUeM_EFp4bXUhRQWxK7pr1iqT90NwAV5H7cJHsp3W4WacBE5uuhXaeXHmE3kz_8V8JusB3ij_Bdyzid2NAB4B6rc5EA |
| link.rule.ids | 783 |
| linkProvider | National Library of Medicine |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=SGLT-2+inhibition+with+canagliflozin%3A+a+new+option+for+the+treatment+of+type+2+diabetes&rft.jtitle=Deutsche+medizinische+Wochenschrift+%281946%29&rft.au=Seufert%2C+J&rft.date=2014-02-01&rft.eissn=1439-4413&rft.volume=139+Suppl+2&rft.spage=S52&rft_id=info:doi/10.1055%2Fs-0033-1359991&rft_id=info%3Apmid%2F24481633&rft_id=info%3Apmid%2F24481633&rft.externalDocID=24481633 |